Multinational Association of Supportive Care in Cancer International Symposium | Conference

Dr. Grunberg on Barriers to Effective Supportive Care

July 19th 2012

Steven M. Grunberg, MD, University of Vermont, on Barriers to Providing Effective Supportive Care for Patients with Cancer.

Dr. Hesketh on Barriers to MASCC Guideline Compliance

July 19th 2012

Paul J. Hesketh, MD, from Lahey Clinic Medical Center, on Barriers to Multinational Association of Supportive Care in Cancer Guideline Compliance

Dr. Anthony on Targeted Therapy Associated Diarrhea

July 16th 2012

Dr. Lowell Anthony from the University of Kentucky Markey Cancer Center on Targeted Therapy Associated Diarrhea.

Paul Jacobsen Discusses Survivorship Rehabilitation

July 9th 2012

Paul Jacobsen, from H. Lee Moffitt Cancer Center and Research Institute, Discusses Cancer Survivorship Rehabilitation.

Dr. Lichtman Discusses Supportive and Palliative Care

July 5th 2012

Dr. Stuart Lichtman, from Memorial Sloan-Kettering Cancer Center Commack, Explains the Benefits of Supportive and Palliative Care.

Donna Berry on Compliance to Oral Cancer Therapies

July 3rd 2012

Donna Berry, from Dana-Farber Cancer Institute, on Compliance to Oral Cancer Therapies.

Dr. Crawford on Managing Febrile Neutropenia

July 2nd 2012

Jeffrey Crawford, MD, from Duke University Medical Center, on Managing Febrile Neutropenia.

Photos From the 2012 MASCC/ISOO Symposium

July 2nd 2012

A compilation of photos from the 2012 combined conferences of the Multinational Association of Supportive Care in Cancer (MASCC) and the International Society of Oral Oncology (ISOO).

Dr. Holland on the Stigma Toward Psychosocial Care

June 30th 2012

Dr. Jimmie Holland, from Memorial Sloan-Kettering Cancer Center, on the Stigma Toward Psychosocial Care.

Diarrhea Less Severe With Molecularly Targeted Agents Than With Standard Chemotherapy

June 30th 2012

Recent evidence shows that some of the newer molecularly targeted therapies can cause diarrhea, which can lead to dose reductions and alterations.

Targeted Therapies Safer for Heart Than Anthracyclines

June 30th 2012

Although molecularly targeted agents can cause cardiac damage, it appears to be reversible and related to cellular dysfunction, as distinct from agents such as anthracyclines that cause cellular death and irreversible cardiac dysfunction.

Dr. Gralla on Chemotherapy-Induced Nausea and Vomiting

June 30th 2012

Dr. Richard Gralla, from the Quality of Life Research Associates, on Chemotherapy-Induced Nausea and Vomiting.

Dr. Foley Discusses Guidelines for Cancer Pain Management

June 29th 2012

Dr. Kathleen Foley, from Memorial Sloan-Kettering Cancer Center, Discusses the World Health Organization Guidelines for Cancer Pain Management.

Dr. Grunberg Describes the MASCC International Symposium

June 29th 2012

Dr. Steven Grunberg, from the Vermont Cancer Center, Describes the 2012 Multinational Association of Supportive Care in Cancer Symposium.

Despite Progress, Complete Control of Chemotherapy-Induced Nausea Lags Behind Vomiting Control

June 29th 2012

Control of chemotherapy-induced nausea and vomiting (CINV) has come a long way in the past 30 years. Thirty years ago, about 10% of patients had complete control of emesis; in the 1990s about 50% had complete control. Today about 85% of patients treated with highly emetogenic chemotherapy have complete control of emesis.

Three Decades of Progress in Treating Febrile Neutropenia

June 29th 2012

Treatment of febrile neutropenia (FN) has dramatically improved over the past 3 decades, but there is room for improvement, according to Jean Klastersky, MD, Institut Jules Bordet, Brussels, Belgium.